Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
出版年份 2020 全文链接
标题
Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
作者
关键词
Chemotherapy, Hypoxia, Inflammation, Microenvironment, Multidrug resistance, Small molecules, Targeted therapy
出版物
DRUG RESISTANCE UPDATES
Volume 53, Issue -, Pages 100715
出版商
Elsevier BV
发表日期
2020-06-20
DOI
10.1016/j.drup.2020.100715
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer
- (2020) Varun Sasidharan Nair et al. Clinical Epigenetics
- Epithelial to Mesenchymal Transition: A Mechanism that Fuels Cancer Radio/Chemoresistance
- (2020) József Dudás et al. Cells
- Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
- (2020) Yolla Haibe et al. Frontiers in Oncology
- NK1R antagonist decreases inflammation and metastasis of breast carcinoma cells metastasized to liver but not to brain; phenotype-dependent therapeutic and toxic consequences
- (2020) Esra Nizam et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk
- (2020) Poonam Sarode et al. Frontiers in Oncology
- CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
- (2020) Yanan Gao et al. PHARMACOLOGICAL RESEARCH
- Epithelial-Mesenchymal Transition in Cancer: A Historical Overview
- (2020) Domenico Ribatti et al. Translational Oncology
- The effect of everolimus and low-dose cyclophosphamide on immune cell subsets in patients with metastatic renal cell carcinoma: results from a phase I clinical trial
- (2019) Charlotte M. Huijts et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The role and mechanisms of action of microRNAs in cancer drug resistance
- (2019) Wengong Si et al. Clinical Epigenetics
- TIAM1 promotes chemoresistance and tumor invasiveness in colorectal cancer
- (2019) Daisuke Izumi et al. Cell Death & Disease
- Current perspectives of cancer-associated fibroblast in therapeutic resistance: potential mechanism and future strategy
- (2019) Dhruba Kadel et al. CELL BIOLOGY AND TOXICOLOGY
- Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance
- (2019) Micol Eleonora Fiori et al. Molecular Cancer
- Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment
- (2019) Ying Li et al. MOLECULAR PHARMACEUTICS
- Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells
- (2019) Xiteng Yin et al. CELLULAR ONCOLOGY
- Azoreductase-Responsive Metal–Organic Framework-Based Nanodrug for Enhanced Cancer Therapy via Breaking Hypoxia-induced Chemoresistance
- (2019) Caixia Huang et al. ACS Applied Materials & Interfaces
- Single-cell Analysis Reveals a Preexisting Drug-Resistant Subpopulation in the Luminal Breast Cancer Subtype
- (2019) Marta Prieto-Vila et al. CANCER RESEARCH
- Retinoblastoma Inactivation Induces a Protumoral Microenvironment via Enhanced CCL2 Secretion
- (2019) Fengkai Li et al. CANCER RESEARCH
- Exosomes and their role in tumorigenesis and anticancer drug resistance
- (2019) Neta Milman et al. DRUG RESISTANCE UPDATES
- Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
- (2019) Edo Kon et al. DRUG RESISTANCE UPDATES
- Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide
- (2019) Kazuyo Yamamoto et al. IMMUNOLOGY LETTERS
- Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications
- (2019) Yuxin Lin et al. Journal of Hematology & Oncology
- Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature
- (2019) Salvatore Grisanti et al. Journal of Neurosurgical Sciences
- Blockade of TGF-β signaling to enhance the antitumor response is accompanied by dysregulation of the functional activity of CD4+CD25+Foxp3+ and CD4+CD25−Foxp3+ T cells
- (2019) Magdalena J. Polanczyk et al. Journal of Translational Medicine
- Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment
- (2019) Xiao-Jing Chen et al. Cell Death & Disease
- Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells
- (2019) Menghan Liu et al. Journal of Clinical Medicine
- Effects of metformin and phenformin on apoptosis and epithelial‐mesenchymal transition in chemoresistant rectal cancer
- (2019) Ji‐Hye Park et al. CANCER SCIENCE
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
- (2019) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
- (2019) Tongyan Liu et al. Journal of Hematology & Oncology
- HSP90 inhibitor PU-H71 increases radiosensitivity of breast cancer cells metastasized to visceral organs and alters the levels of inflammatory mediators
- (2019) Şule Kale et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Treatment sequences for advanced renal cell carcinoma: A health economic assessment
- (2019) Baris Deniz et al. PLoS One
- Fulvestrant Plus Vistusertib vs Fulvestrant Plus Everolimus vs Fulvestrant Alone for Women With Hormone Receptor–Positive Metastatic Breast Cancer
- (2019) Peter Schmid et al. JAMA Oncology
- Management of Small Bowel Neuroendocrine Tumors
- (2019) Larouche et al. Cancers
- Eribulin Synergistically Increases Anti-Tumor Activity of an mTOR Inhibitor by Inhibiting pAKT/pS6K/pS6 in Triple Negative Breast Cancer
- (2019) Wei Wen et al. Cells
- CCL8 secreted by tumor-associated macrophages promotes invasion and stemness of glioblastoma cells via ERK1/2 signaling
- (2019) Xiang Zhang et al. LABORATORY INVESTIGATION
- Wnt signaling and drug resistance in cancer
- (2019) Zheng Zhong et al. MOLECULAR PHARMACOLOGY
- CD200 mimetic aptamer PEG-M49 markedly increases the therapeutic effects of pegylated liposomal doxorubicin in a mouse model of metastatic breast carcinoma: an effect independent of CD200 receptor 1
- (2019) Nuray Erin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor‐associated macrophages secrete CC‐chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer
- (2019) Dongbo Li et al. CANCER SCIENCE
- Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
- (2019) M. Helena Vasconcelos et al. DRUG RESISTANCE UPDATES
- Secretomes reveal several novel proteins as well as TGF-β1 as the top upstream regulator of metastatic process in breast cancer
- (2018) Nuray Erin et al. BREAST CANCER RESEARCH AND TREATMENT
- Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
- (2018) Yongchen Ma et al. Cancer Cell International
- miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer
- (2018) Xinliang Zhou et al. CANCER GENE THERAPY
- Presence of S100A8/Gr1-Positive Myeloid-Derived Suppressor Cells in Primary Tumors and Visceral Organs Invaded by Breast Carcinoma Cells
- (2018) Gamze Tanriover et al. Clinical Breast Cancer
- Antiangiogenic therapy: Markers of response, “normalization” and resistance
- (2018) Karima El Alaoui-Lasmaili et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Plasticity of myeloid-derived suppressor cells in cancer
- (2018) Evgenii Tcyganov et al. CURRENT OPINION IN IMMUNOLOGY
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- Caveolin-1, cancer and therapy resistance
- (2018) Julia Ketteler et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor stressors induce two mechanisms of intracellular P-glycoprotein–mediated resistance that are overcome by lysosomal-targeted thiosemicarbazones
- (2018) Lina Al-Akra et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
- (2018) Suzanne Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway
- (2018) Tianxiao Gong et al. Journal of Translational Medicine
- Aspirin Disrupts the Crosstalk of Angiogenic and Inflammatory Cytokines between 4T1 Breast Cancer Cells and Macrophages
- (2018) Chia-Chien Hsieh et al. MEDIATORS OF INFLAMMATION
- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer
- (2018) Lucy Ireland et al. ONCOGENE
- Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug Resistance in Pancreatic Cancer
- (2018) Lulin Zhang et al. ONCOLOGY RESEARCH
- Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
- (2018) Elisa Peranzoni et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor-associated macrophage-derived cytokines enhance cancer stem-like characteristics through epithelial–mesenchymal transition
- (2018) Yongxu Chen et al. OncoTargets and Therapy
- CD200fc enhances anti-tumoral immune response and inhibits visceral metastasis of breast carcinoma
- (2018) Nuray Erin et al. Oncotarget
- Tumor-targeted hybrid protein oxygen carrier to simultaneously enhance hypoxia-dampened chemotherapy and photodynamic therapy at a single dose
- (2018) Zhenyu Luo et al. Theranostics
- Participation of CCL1 in Snail-Positive Fibroblasts in Colorectal Cancer Contribute to 5-Fluorouracil/Paclitaxel Chemoresistance
- (2018) Ziqian Li et al. Cancer Research and Treatment
- Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
- (2018) Rebekka Weber et al. Frontiers in Immunology
- Bad Company: Microenvironmentally Mediated Resistance to Targeted Therapy in Melanoma
- (2018) Filipe V Almeida et al. Pigment Cell & Melanoma Research
- SOCS3 Suppression Promoted the Recruitment of CD11b+Gr-1−F4/80−MHCII− Early-Stage Myeloid-Derived Suppressor Cells and Accelerated Interleukin-6-Related Tumor Invasion via Affecting Myeloid Differentiation in Breast Cancer
- (2018) Wenwen Zhang et al. Frontiers in Immunology
- TGFβ-Activated USP27X Deubiquitinase Regulates Cell Migration and Chemoresistance via Stabilization of Snail1
- (2018) Guillem Lambies et al. CANCER RESEARCH
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Decitabine shows potent anti-myeloma activity by depleting monocytic myeloid-derived suppressor cells in the myeloma microenvironment
- (2018) Jihao Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Hypoxia‐inducible factor‐2α directly promotes BCRP expression and mediates the resistance of ovarian cancer stem cells to adriamycin
- (2018) Miao He et al. Molecular Oncology
- Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties
- (2018) Thota Ganesh et al. MOLECULAR PHARMACEUTICS
- Turning foes to friends: targeting cancer-associated fibroblasts
- (2018) Xueman Chen et al. NATURE REVIEWS DRUG DISCOVERY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Contribution of FPR and TLR9 to hypoxia-induced chemoresistance of ovarian cancer cells
- (2018) Yongqing Cai et al. OncoTargets and Therapy
- Interactions between interleukin-6 and myeloid-derived suppressor cells drive the chemoresistant phenotype of hepatocellular cancer
- (2017) Min Xu et al. EXPERIMENTAL CELL RESEARCH
- Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome
- (2017) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation of organelle function by metformin
- (2017) Jeongho Kim et al. IUBMB LIFE
- Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells
- (2017) Jihao Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Oxidative Stress Promotes Doxorubicin-Induced Pgp and BCRP Expression in Colon Cancer Cells Under Hypoxic Conditions
- (2017) Martha L. Pinzón-Daza et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells
- (2017) Takumi Tomono et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance
- (2017) Barbara Muz et al. LEUKEMIA & LYMPHOMA
- Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters
- (2017) Gabor J. Szebeni et al. MEDIATORS OF INFLAMMATION
- Hypoxia-inducible factor-1 (HIF-1) inhibitors from the last decade (2007 to 2016): A “structure-activity relationship” perspective
- (2017) Deepak Bhattarai et al. MEDICINAL RESEARCH REVIEWS
- Emerging roles of lipid metabolism in cancer metastasis
- (2017) Xiangjian Luo et al. Molecular Cancer
- Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway
- (2017) Xueyan Zhang et al. Molecular Medicine Reports
- IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma
- (2017) Y Qiao et al. ONCOGENE
- Physical and biological characteristics of multi drug resistance (MDR): An integral approach considering pH and drug resistance in cancer
- (2017) Ziad Omran et al. SEMINARS IN CANCER BIOLOGY
- Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development
- (2017) Lindsay Wilde et al. SEMINARS IN ONCOLOGY
- Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib
- (2017) Dongxu Kang et al. YONSEI MEDICAL JOURNAL
- EGF Induced RET Inhibitor Resistance inCCDC6-RETLung Cancer Cells
- (2017) Hyun Chang et al. YONSEI MEDICAL JOURNAL
- The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
- (2017) Youxiang Hou et al. Cell Death & Disease
- Metformin reverses prostate cancer resistance to enzalutamide by targeting TGF-β1/STAT3 axis-regulated EMT
- (2017) Qiuli Liu et al. Cell Death & Disease
- Snail reprograms glucose metabolism by repressing phosphofructokinase PFKP allowing cancer cell survival under metabolic stress
- (2017) Nam Hee Kim et al. Nature Communications
- Twist1 confers multidrug resistance in colon cancer through upregulation of ATP-binding cassette transporters
- (2017) Yan-Rong Liu et al. Oncotarget
- Extracellular ATP, as an energy and phosphorylating molecule, induces different types of drug resistances in cancer cells through ATP internalization and intracellular ATP level increase
- (2017) Xuan Wang et al. Oncotarget
- Three-dimensional tumor model mimics stromal – breast cancer cells signaling
- (2017) Stephanie Lemmo Ham et al. Oncotarget
- Changes in metabolism affect expression of ABC transporters through ERK5 and depending on p53 status
- (2017) Sana Belkahla et al. Oncotarget
- Down-regulation of miR-29b in carcinoma associated fibroblasts promotes cell growth and metastasis of breast cancer
- (2017) Yonglei Liu et al. Oncotarget
- Integration of phytochemicals and phytotherapy into cancer precision medicine
- (2017) Thomas Efferth et al. Oncotarget
- CCR5 Directs the Mobilization of CD11b + Gr1 + Ly6C low Polymorphonuclear Myeloid Cells from the Bone Marrow to the Blood to Support Tumor Development
- (2017) Elias Hawila et al. Cell Reports
- Suppression of TGF-β1 enhances chemosensitivity of cisplatin-resistant lung cancer cells through the inhibition of drug-resistant proteins
- (2017) Jin Wang et al. Artificial Cells Nanomedicine and Biotechnology
- ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC
- (2017) Darina Lazarova et al. Journal of Cancer
- HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins
- (2017) Lei Sun et al. Journal of Cancer
- Targeting Hypoxia to Improve Non–Small Cell Lung Cancer Outcome
- (2017) Ahmed Salem et al. JNCI-Journal of the National Cancer Institute
- Depletion of Tumor-Associated Macrophages with a CSF-1R Kinase Inhibitor Enhances Antitumor Immunity and Survival Induced by DC Immunotherapy
- (2017) Floris Dammeijer et al. Cancer Immunology Research
- Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
- (2017) Michael A. Cannarile et al. Journal for ImmunoTherapy of Cancer
- Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles
- (2017) Vanessa Lopes-Rodrigues et al. Scientific Reports
- Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
- (2016) Robert H. I. Andtbacka et al. ANNALS OF SURGICAL ONCOLOGY
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- l-carnosine dipeptide overcomes acquired resistance to 5-fluorouracil in HT29 human colon cancer cells via downregulation of HIF1-alpha and induction of apoptosis
- (2016) Barbara Iovine et al. BIOCHIMIE
- Histone deacetylase inhibitors for cancer therapy: An evolutionarily ancient resistance response may explain their limited success
- (2016) John A. Halsall et al. BIOESSAYS
- Inhibition of autophagy sensitizes MDR-phenotype ovarian cancer SKVCR cells to chemotherapy
- (2016) Bing Liang et al. BIOMEDICINE & PHARMACOTHERAPY
- Oncolytic Virus-Mediated Targeting of PGE 2 in the Tumor Alters the Immune Status and Sensitizes Established and Resistant Tumors to Immunotherapy
- (2016) Weizhou Hou et al. CANCER CELL
- Histone deacetylase inhibitors deplete myeloid-derived suppressor cells induced by 4T1 mammary tumors in vivo and in vitro
- (2016) Hai-Fang Wang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement
- (2016) Rashmi Bharti et al. CANCER LETTERS
- A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors
- (2016) Haihong Zhong et al. CANCER RESEARCH
- Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
- (2016) Willy Hugo et al. CELL
- Reprogramming of macrophages — new opportunities for therapeutic targeting
- (2016) Joachim L Schultze CURRENT OPINION IN PHARMACOLOGY
- Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
- (2016) Morteza Ghandadi et al. CURRENT PHARMACEUTICAL DESIGN
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Twist mediates an aggressive phenotype in human colorectal cancer cells
- (2016) JUN-JIAN DENG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Gemcitabine reduces MDSCs, tregs and TGFβ-1 while restoring the teff/treg ratio in patients with pancreatic cancer
- (2016) Emma Eriksson et al. Journal of Translational Medicine
- Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK
- (2016) P. A. Toste et al. MOLECULAR CANCER RESEARCH
- The hypoxia-mimetic agent CoCl2 induces chemotherapy resistance in LOVO colorectal cancer cells
- (2016) GUANGLEI YANG et al. Molecular Medicine Reports
- New insights into the multidimensional concept of macrophage ontogeny, activation and function
- (2016) Florent Ginhoux et al. NATURE IMMUNOLOGY
- mir-1-mediated paracrine effect of cancer-associated fibroblasts on lung cancer cell proliferation and chemoresistance
- (2016) JIANMIN LI et al. ONCOLOGY REPORTS
- Knockdown of Hypoxia-Inducible Factor 1α Improved the Efficacy of Low-Dose Metronomic Chemotherapy of Paclitaxel in Human Colon Cancer Xenografts
- (2016) Mu Zhang et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β
- (2016) N Yoon et al. Cell Death & Disease
- Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
- (2016) Mila Gugnoni et al. Cell Death & Disease
- Expression of HIF-1α and P-gp in non-small cell lung cancer and the relationship with HPV infection
- (2016) Yimin Lu et al. Oncology Letters
- Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival
- (2016) Edoardo Gaude et al. Nature Communications
- Hypoxia can impair doxorubicin resistance of non-small cell lung cancer cells by inhibiting MRP1 and P-gp expression and boosting the chemosensitizing effects of MRP1 and P-gp blockers
- (2016) Yu-Lun Chen et al. CELLULAR ONCOLOGY
- Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors
- (2016) Kotryna Seip et al. Oncotarget
- Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment
- (2016) Eric T. Alexander et al. Oncotarget
- Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance
- (2016) Onat Kadioglu et al. Scientific Reports
- G-CSF is a key modulator of MDSC and could be a potential therapeutic target in colitis-associated colorectal cancers
- (2016) Wenbin Li et al. Protein & Cell
- Mesenchymal Stem/Stromal Cells in Stromal Evolution and Cancer Progression
- (2016) Francesca Cammarota et al. Stem Cells International
- CXCL1-Mediated Interaction of Cancer Cells with Tumor-Associated Macrophages and Cancer-Associated Fibroblasts Promotes Tumor Progression in Human Bladder Cancer
- (2016) Makito Miyake et al. NEOPLASIA
- Fundamentals of cancer metabolism
- (2016) R. J. DeBerardinis et al. Science Advances
- Glycosylation in Cancer: Interplay between Multidrug Resistance and Epithelial-to-Mesenchymal Transition?
- (2016) Leonardo Marques da Fonseca et al. Frontiers in Oncology
- ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer
- (2016) Takeshi Yoshida et al. PLoS One
- NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer
- (2015) Ming Zhan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines
- (2015) Karolina Wojtowicz et al. BIOMEDICINE & PHARMACOTHERAPY
- Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis
- (2015) Eric T Alexander et al. CANCER BIOLOGY & THERAPY
- FOXC2 promotes chemoresistance in nasopharyngeal carcinomas via induction of epithelial mesenchymal transition
- (2015) Zhijiao Zhou et al. CANCER LETTERS
- FOXF2 suppresses the FOXC2-mediated epithelial–mesenchymal transition and multidrug resistance of basal-like breast cancer
- (2015) Jun Cai et al. CANCER LETTERS
- TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma
- (2015) Naoki Oshimori et al. CELL
- Metabolic changes associated with tumor metastasis, part 2: Mitochondria, lipid and amino acid metabolism
- (2015) Paolo E. Porporato et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Molecular Pathways: Targeting Tumor-Infiltrating Myeloid-Derived Suppressor Cells for Cancer Therapy
- (2015) D. Di Mitri et al. CLINICAL CANCER RESEARCH
- SIRT1/PGC1 -Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer
- (2015) T. T. Vellinga et al. CLINICAL CANCER RESEARCH
- Molecular basis of resistance to proteasome inhibitors in hematological malignancies
- (2015) Denise Niewerth et al. DRUG RESISTANCE UPDATES
- ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat
- (2015) S. Meidhof et al. EMBO Molecular Medicine
- Acquired BRAF inhibitor resistance: A multicenter meta-analysis of the spectrum and frequencies, clinical behaviour, and phenotypic associations of resistance mechanisms
- (2015) Douglas B. Johnson et al. EUROPEAN JOURNAL OF CANCER
- Diminution of miR-340-5p levels is responsible for increased expression of ABCB5 in melanoma cells under oxygen-deprived conditions
- (2015) Michal Wozniak et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α
- (2015) Hui Gao et al. EXPERIMENTAL CELL RESEARCH
- CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
- (2015) YueGuo Li et al. Hepatology International
- Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma
- (2015) Christine Lu-Emerson et al. JOURNAL OF CLINICAL ONCOLOGY
- Multiple myeloma
- (2015) Christoph Röllig et al. LANCET
- Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer
- (2015) Xiaofeng Zheng et al. NATURE
- Benzyl butyl phthalate increases the chemoresistance to doxorubicin/cyclophosphamide by increasing breast cancer-associated dendritic cell-derived CXCL1/GROα and S100A8/A9
- (2015) YA-LING HSU et al. ONCOLOGY REPORTS
- Epithelial–mesenchymal transition in human cancer: Comprehensive reprogramming of metabolism, epigenetics, and differentiation
- (2015) Linna Li et al. PHARMACOLOGY & THERAPEUTICS
- Dopamine induces growth inhibition and vascular normalization through reprogramming M2-polarized macrophages in rat C6 glioma
- (2015) Tian Qin et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
- (2015) Yingqian Lv et al. OncoTargets and Therapy
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway
- (2015) Sheng-Chun Wang et al. Oncotarget
- Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site
- (2015) Maxime Thoreau et al. Oncotarget
- A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy
- (2015) Ruth Sánchez-Martínez et al. Oncotarget
- Tumor-associated fibroblast-conditioned medium induces CDDP resistance in HNSCC cells
- (2015) Teresa Bernadette Steinbichler et al. Oncotarget
- The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer
- (2015) Mahiru Kawano et al. Scientific Reports
- Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
- (2015) Manfred Volm et al. Frontiers in Oncology
- Caveolae and cancer: A new mechanical perspective
- (2015) Christophe Lamaze et al. Biomedical Journal
- Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
- (2015) Kamolporn Amornsupak et al. BMC CANCER
- FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
- (2015) Wen-Tai Chiu et al. Oncotarget
- The plant alkaloid voacamine induces apoptosis-independent autophagic cell death on both sensitive and multidrug resistant human osteosarcoma cells
- (2014) Stefania Meschini et al. Autophagy
- Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner
- (2014) Heyang Xu et al. BMC CANCER
- G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration
- (2014) K T Morris et al. BRITISH JOURNAL OF CANCER
- SOX2 regulates self-renewal and tumorigenicity of stem-like cells of head and neck squamous cell carcinoma
- (2014) S H Lee et al. BRITISH JOURNAL OF CANCER
- Extracellular ATP is internalized by macropinocytosis and induces intracellular ATP increase and drug resistance in cancer cells
- (2014) Yanrong Qian et al. CANCER LETTERS
- Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Qing-Min Fan et al. CANCER LETTERS
- Krüppel-like factor 8 contributes to hypoxia-induced MDR in gastric cancer cells
- (2014) Hui Zhang et al. CANCER SCIENCE
- Lung Cancer Stem Cells and Implications for Future Therapeutics
- (2014) Jing Wang et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Autophagy Inhibition Augments the Anticancer Effects of Epirubicin Treatment in Anthracycline-Sensitive and -Resistant Triple-Negative Breast Cancer
- (2014) S. Chittaranjan et al. CLINICAL CANCER RESEARCH
- Cancer stem cells - important players in tumor therapy resistance
- (2014) Selcuk Colak et al. FEBS Journal
- CX3 CR1 delineates temporally and functionally distinct subsets of myeloid-derived suppressor cells in a mouse model of ovarian cancer
- (2014) Kevin M Hart et al. IMMUNOLOGY AND CELL BIOLOGY
- Cancer stem cells and radioresistance
- (2014) Kiera Rycaj et al. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
- Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
- (2014) LINGJIE BAO et al. Molecular Medicine Reports
- Metformin reverses multidrug resistance in human hepatocellular carcinoma Bel-7402/5-fluorouracil cells
- (2014) SUNBIN LING et al. Molecular Medicine Reports
- Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
- (2014) Oscar R. Colegio et al. NATURE
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1
- (2014) Peijing Zhang et al. NATURE CELL BIOLOGY
- PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
- (2014) Valerie S. LeBleu et al. NATURE CELL BIOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bidirectional effect of CD200 on breast cancer development and metastasis, with ultimate outcome determined by tumor aggressiveness and a cancer-induced inflammatory response
- (2014) N Erin et al. ONCOGENE
- Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
- (2014) L Jiang et al. ONCOGENE
- Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells
- (2014) LAURA RONCUZZI et al. ONCOLOGY REPORTS
- Effect of oxygen on multidrug resistance in term human placenta
- (2014) M. Javam et al. PLACENTA
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth
- (2014) Ubaldo E. Martinez-Outschoorn et al. SEMINARS IN CANCER BIOLOGY
- Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest
- (2014) S Raz et al. Cell Death & Disease
- T-Cell and NK-Cell Infiltration into Solid Tumors: A Key Limiting Factor for Efficacious Cancer Immunotherapy
- (2014) I. Melero et al. Cancer Discovery
- Tumor Initiating Cells and Chemoresistance: Which Is the Best Strategy to Target Colon Cancer Stem Cells?
- (2014) Emanuela Paldino et al. Biomed Research International
- Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis
- (2014) William W Wheaton et al. eLife
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator
- (2013) Philip Vlaicu et al. BMC CANCER
- Macrophage Regulation of Tumor Responses to Anticancer Therapies
- (2013) Michele De Palma et al. CANCER CELL
- Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
- (2013) E. M. Dijkgraaf et al. CANCER RESEARCH
- Metformin Decreases Glucose Oxidation and Increases the Dependency of Prostate Cancer Cells on Reductive Glutamine Metabolism
- (2013) S.-M. Fendt et al. CANCER RESEARCH
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- (2013) Florian A. Siebzehnrubl et al. EMBO Molecular Medicine
- A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: Results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO)
- (2013) Gary Middleton et al. EUROPEAN JOURNAL OF CANCER
- Tumor Necrosis Factor-α Blocks Differentiation and Enhances Suppressive Activity of Immature Myeloid Cells during Chronic Inflammation
- (2013) Moshe Sade-Feldman et al. IMMUNITY
- Host immunity contributes to the anti-melanoma activity of BRAF inhibitors
- (2013) Deborah A. Knight et al. JOURNAL OF CLINICAL INVESTIGATION
- STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
- (2013) David Vasquez-Dunddel et al. JOURNAL OF CLINICAL INVESTIGATION
- Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A
- (2013) Fiorenza Lotti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
- (2013) A. Sevko et al. JOURNAL OF IMMUNOLOGY
- Multi-Drug–Resistant Cells Enriched From Chronic Myeloid Leukemia Cells by Doxorubicin Possess Tumor-Initiating–Cell Properties
- (2013) Hong Xin et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas
- (2013) I Sakamaki et al. LEUKEMIA
- Metformin reverses multidrug resistance and epithelial–mesenchymal transition (EMT) via activating AMP-activated protein kinase (AMPK) in human breast cancer cells
- (2013) Chen Qu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Effects of HDM2 antagonism on sunitinib resistance, p53 activation, SDF-1 induction, and tumor infiltration by CD11b+/Gr-1+ myeloid derived suppressor cells
- (2013) David J Panka et al. Molecular Cancer
- Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer
- (2013) Jeong Heo et al. NATURE MEDICINE
- Candidate Markers That Associate with Chemotherapy Resistance in Breast Cancer through the Study on Taxotere-Induced Damage to Tumor Microenvironment and Gene Expression Profiling of Carcinoma-Associated Fibroblasts (CAFs)
- (2013) Guohua Rong et al. PLoS One
- The role of IL-6 in the radiation response of prostate cancer
- (2013) Chun-Te Wu et al. Radiation Oncology
- Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
- (2013) L. M. Coussens et al. SCIENCE
- Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux
- (2013) Jian-ri Li et al. TOXICOLOGY LETTERS
- Pleiotropic actions of miR-21 highlight the critical role of deregulated stromal microRNAs during colorectal cancer progression
- (2013) M D Bullock et al. Cell Death & Disease
- Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment
- (2013) X Sui et al. Cell Death & Disease
- Expression and significance of hypoxia-inducible factor-1α and MDR1/P-glycoprotein in laryngeal carcinoma tissue and hypoxic Hep-2 cells
- (2013) JIN XIE et al. Oncology Letters
- Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
- (2013) Younghun Jung et al. Nature Communications
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- HIF-1 activation induces doxorubicin resistance in MCF7 3-D spheroids via P-glycoprotein expression: a potential model of the chemo-resistance of invasive micropapillary carcinoma of the breast
- (2012) Sophie Doublier et al. BMC CANCER
- Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology
- (2012) Claudia A. Dumitru et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Wnt/Snail Signaling Regulates Cytochrome c Oxidase and Glucose Metabolism
- (2012) S. Y. Lee et al. CANCER RESEARCH
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses
- (2012) J. B. Mitchem et al. CANCER RESEARCH
- MED12 Controls the Response to Multiple Cancer Drugs through Regulation of TGF-β Receptor Signaling
- (2012) Sidong Huang et al. CELL
- A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
- (2012) Swarnali Acharyya et al. CELL
- A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells
- (2012) Yan Zhang et al. CELL RESEARCH
- Targeting monocyte chemotactic protein-1 synthesis with bindarit induces tumor regression in prostate and breast cancer animal models
- (2012) Massimo Zollo et al. CLINICAL & EXPERIMENTAL METASTASIS
- Molecular Link Mechanisms between Inflammation and Cancer
- (2012) D. B. Vendramini-Costa et al. CURRENT PHARMACEUTICAL DESIGN
- Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
- (2012) Nitzan Gonen et al. DRUG RESISTANCE UPDATES
- Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
- (2012) Patsy S H Soon et al. ENDOCRINE-RELATED CANCER
- Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
- (2012) Chin Hao Chang et al. INTERNATIONAL JOURNAL OF CANCER
- Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
- (2012) L. Wang et al. JOURNAL OF IMMUNOLOGY
- Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
- (2012) E. Schlecker et al. JOURNAL OF IMMUNOLOGY
- Monocyte chemoattractant protein-1 mediates angiotensin II-induced vascular smooth muscle cell proliferation via SAPK/JNK and ERK1/2
- (2012) Hua-Li Yao et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Therapeutic Delivery of siRNA Silencing HIF-1 Alpha with Micellar Nanoparticles Inhibits Hypoxic Tumor Growth
- (2012) Xi-Qiu Liu et al. MOLECULAR PHARMACEUTICS
- Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
- (2012) Chii-Wen Chou et al. NEURO-ONCOLOGY
- TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression
- (2012) MARÍA CECILIA DAROQUI et al. ONCOLOGY REPORTS
- Short hairpin RNA targeting Twist1 suppresses cell proliferation and improves chemosensitivity to cisplatin in HeLa human cervical cancer cells
- (2012) KEXIU ZHU et al. ONCOLOGY REPORTS
- Induction of epithelial–mesenchymal transition by transforming growth factor β
- (2012) Aristidis Moustakas et al. SEMINARS IN CANCER BIOLOGY
- Melanoma-induced immunosuppression and its neutralization
- (2012) Viktor Umansky et al. SEMINARS IN CANCER BIOLOGY
- Differential macrophage programming in the tumor microenvironment
- (2012) Brian Ruffell et al. TRENDS IN IMMUNOLOGY
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Multidrug resistance in breast cancer cells during epithelial-mesenchymal transition is modulated by breast cancer resistant protein
- (2012) Wei-Juan Chen et al. Chinese Journal of Cancer
- Autophagy protects breast cancer cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance development
- (2011) Wei-Liang Sun et al. Autophagy
- Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells
- (2011) N. Obermajer et al. BLOOD
- HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PlGF
- (2011) Charlotte Rolny et al. CANCER CELL
- Targeting the ANG2/TIE2 Axis Inhibits Tumor Growth and Metastasis by Impairing Angiogenesis and Disabling Rebounds of Proangiogenic Myeloid Cells
- (2011) Roberta Mazzieri et al. CANCER CELL
- Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells
- (2011) Y. Zhou et al. CANCER RESEARCH
- COX-2 Blockade Suppresses Gliomagenesis by Inhibiting Myeloid-Derived Suppressor Cells
- (2011) M. Fujita et al. CANCER RESEARCH
- The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
- (2011) Stephanos Pavlides et al. CELL CYCLE
- SIRT1, metabolism and cancer
- (2011) John R.P. Knight et al. CURRENT OPINION IN ONCOLOGY
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Phase II trial of lapatinib and topotecan (LapTop) in patients with platinum-refractory/resistant ovarian and primary peritoneal carcinoma
- (2011) S. John Weroha et al. GYNECOLOGIC ONCOLOGY
- Regulation of hypoxia inducible factor-1α expression by the alteration of redox status in HepG2 cells
- (2011) Wen-sen Jin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
- (2011) M. Heusinkveld et al. JOURNAL OF IMMUNOLOGY
- Regulation of Immune Responses by Prostaglandin E2
- (2011) P. Kalinski JOURNAL OF IMMUNOLOGY
- The chemotherapy metabolite acrolein upregulates thrombin generation and impairs the protein C anticoagulant pathway in animal-based and cell-based models
- (2011) L. L. SWYSTUN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Interleukin-6: A multifunctional targetable cytokine in human prostate cancer
- (2011) Zoran Culig et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- p38 MAPK Controls Prothrombin Expression by Regulated RNA 3′ End Processing
- (2011) Sven Danckwardt et al. MOLECULAR CELL
- Sox2 expression in breast tumours and activation in breast cancer stem cells
- (2011) O Leis et al. ONCOGENE
- Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells
- (2011) M. Jinushi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model
- (2011) C. Meyer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism
- (2011) M Donadelli et al. Cell Death & Disease
- Transcription factors that mediate epithelial–mesenchymal transition lead to multidrug resistance by upregulating ABC transporters
- (2011) M Saxena et al. Cell Death & Disease
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation
- (2010) Hyung Gyun Kim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy
- (2010) Isabelle Mercier et al. CANCER BIOLOGY & THERAPY
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts
- (2010) Gloria Bonuccelli et al. CELL CYCLE
- Metformin regulates breast cancer stem cello ntogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
- (2010) Alejandro Vazquez-Martin et al. CELL CYCLE
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Inflammation and coagulation
- (2010) Marcel Levi et al. CRITICAL CARE MEDICINE
- Expression and significance of hypoxia-inducible factor-1 alpha and MDR1/P-glycoprotein in human colon carcinoma tissue and cells
- (2010) Zhenyu Ding et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319
- (2010) Zhengang Ji et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol
- (2010) Ming Zhou et al. Molecular Cancer
- Antitumor effect of novel small chemical inhibitors of Snail-p53 binding in K-Ras-mutated cancer cells
- (2010) S-H Lee et al. ONCOGENE
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- TGF- IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer
- (2010) Z. Yao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes
- (2010) M. Kowanetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Macrophages as mediators of tumor immunosurveillance
- (2010) Siddhartha Jaiswal et al. TRENDS IN IMMUNOLOGY
- An Absence of Stromal Caveolin-1 Expression Predicts Early Tumor Recurrence and Poor Clinical Outcome in Human Breast Cancers
- (2009) Agnieszka K. Witkiewicz et al. AMERICAN JOURNAL OF PATHOLOGY
- Inflammation and Cancer: IL-6 and STAT3 Complete the Link
- (2009) Jacqueline Bromberg et al. CANCER CELL
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer
- (2009) T. Arumugam et al. CANCER RESEARCH
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Tumor and Host-Mediated Pathways of Resistance and Disease Progression in Response to Antiangiogenic Therapy
- (2009) J. M. L. Ebos et al. CLINICAL CANCER RESEARCH
- Twist1-Mediated Adriamycin-Induced Epithelial-Mesenchymal Transition Relates to Multidrug Resistance and Invasive Potential in Breast Cancer Cells
- (2009) Q.-Q. Li et al. CLINICAL CANCER RESEARCH
- Transforming growth factor beta (TGF-β) and inflammation in cancer
- (2009) Brian Bierie et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Granulocyte colony-stimulating factor receptor: Stimulating granulopoiesis and much more
- (2009) Clifford Liongue et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- FDA Drug Approval Summary: Bevacizumab (Avastin(R)) as Treatment of Recurrent Glioblastoma Multiforme
- (2009) M. H. Cohen et al. ONCOLOGIST
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted inhibition of Snail family zinc finger transcription factors by oligonucleotide-Co(III) Schiff base conjugate
- (2009) A. S. Harney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Snail and Slug Mediate Radioresistance and Chemoresistance by Antagonizing p53-Mediated Apoptosis and Acquiring a Stem-Like Phenotype in Ovarian Cancer Cells
- (2009) Nawneet K. Kurrey et al. STEM CELLS
- Digoxin and ouabain induce P-glycoprotein by activating calmodulin kinase II and hypoxia-inducible factor-1α in human colon cancer cells
- (2009) Chiara Riganti et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Autocrine IL-6 Signaling: A Key Event in Tumorigenesis?
- (2008) Sergei Grivennikov et al. CANCER CELL
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Carcinoma-Associated Fibroblast-Like Differentiation of Human Mesenchymal Stem Cells
- (2008) P. J. Mishra et al. CANCER RESEARCH
- Insulin-like Growth Factor-I-Dependent Up-regulation of ZEB1 Drives Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells
- (2008) T. R. Graham et al. CANCER RESEARCH
- RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
- (2008) Olga Turovskaya et al. CARCINOGENESIS
- Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2
- (2008) L Moro et al. CELL DEATH AND DIFFERENTIATION
- The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
- (2008) Paola Allavena et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- “Re-educating” tumor-associated macrophages by targeting NF-κB
- (2008) Thorsten Hagemann et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Glucocorticoids induce an activated, anti-inflammatory monocyte subset in mice that resembles myeloid-derived suppressor cells
- (2008) Georg Varga et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Hypoxia induces resistance to 5-fluorouracil in oral cancer cells via G1 phase cell cycle arrest
- (2008) Sayaka Yoshiba et al. ORAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now